Dear Reader,
Pretty soon, the pandemic will be over.
And most of our lives will go back to normal.
But there is ONE pandemic habit that will not change.
And it’s triggering a flood of money into one niche sector of the stock market.
<The 5 Tech Giants of the 2020s>
Sincerely,
Sam Latter
Editor-in-Chief
Altimetry Research
Overview & Barzolvolimab Breakthrough Celldex Therapeutics (NASDAQ: CLDX) is a clinical-stage biotech focused on immunology, and it recently drew significant attention after unveiling compelling results
Daily Financial Update Good morning, team. It’s Sunday, June 14. Here’s your straight-talking roundup of yesterday’s headlines and what to watch for as markets open.
Overview: X-Energy, Inc. (NASDAQ: XE) is a newly listed developer of advanced nuclear reactors and fuel, backed by significant strategic investors and government support. The
